Thiotepa 25021-0246
Product NDC
25021-0246- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intracavitary, Intravenous, And Intravesical
- Product Type
- Human Prescription Drug
- Marketing Start
- June 15, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA209150
Need to source Thiotepa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Thiotepa | 15 mg/1.5mL |
Drug Class
Alkylating Drug [EPC]Alkylating Activity [MoA]Alkylating Drug [EPC]
Packaging Options(1)
1 VIAL in 1 CARTON (25021-246-02) / 1.5 mL in 1 VIAL